Price $70.29 |
Market Cap
21.24B
|
Sector Health Care |
Div. Growth
12.10%
|
|
P/E
19.0
|
P/B
4.15
|
P/S
4.23
|
Dividend %
1.00%
|
|
P/CF
-
|
P/FCF
31.4
|
Op. Cash Flow
1.03M
|
FCF
2.1
|
|
Op. Margin
18.70%
|
Net Margin
22.30%
|
ROE
23.20%
|
ROI
13.60%
|
|
ROA
12.80%
|
EPS Growth
373.80%
|
Current Ratio
3.3
|
Debt/Equity
39.40%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Champions Oncology Inc (CSBR) | $8.79 | - | - | 110.8M | Strong Buy |
| Dyadic International, Inc. (DYAI) | $6.24 | - | - | 120.1M | Strong Buy |
| Assertio Therapeutics Inc (ASRT) | $3.00 | - | - | 202.9M | Strong Buy |
| Celexus Inc (CXUS) | $1.35 | - | - | 5.2M | Strong Buy |
| DURECT Corporation (DRRX) | $0.51 | - | - | 86M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
